Current Status, Goals, and Research Agenda for Outcome Measures Development in Behcet Syndrome: Report from OMERACT 2014

HATEMİ G., Ozguler Y., Direskeneli H., Mahr A., Gul A., Levi V., ...Daha Fazla

JOURNAL OF RHEUMATOLOGY, cilt.42, sa.12, ss.2436-2441, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 12
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3899/jrheum.141147
  • Dergi Adı: JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2436-2441
  • Anahtar Kelimeler: BEHCET SYNDROME, OUTCOME MEASURES, OUTCOMES, CLINICAL-TRIALS, DISEASE, ONSET
  • Marmara Üniversitesi Adresli: Evet

Özet

Objective. There is an unmet need for reliable, validated, and widely accepted outcomes and outcome measures for use in clinical trials in Behcet syndrome (BS). Our report summarizes initial steps taken by the Outcome Measures in Rheumatology (OMERACT) vasculitis working group toward developing a core set of outcome measures for BS according to the OMERACT methodology, including the OMERACT Filter 2.0, and discussions during the first meeting of the BS working group held during OMERACT 12 (2014).